Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma
- 1 June 2007
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (9), 1467-1475
- https://doi.org/10.1016/j.ejca.2007.03.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Regions syntenic to human 17q are gained in mouse and rat neuroblastomaGenes, Chromosomes and Cancer, 2004
- MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaOncogene, 2004
- Effects of MYCN Antisense Oligonucleotide Administration on Tumorigenesis in a Murine Model of NeuroblastomaJNCI Journal of the National Cancer Institute, 2003
- Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.2003
- A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumorsCancer Letters, 2003
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.2000
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1999
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984